cancer risk

FDA- Losartan Latest Blood pressure Drug Recalled for possible cancer risk

November 14, 2018

Losartan Latest BP Drug Recalled for Contamination Nov. 13, 2018 — Yet another blood pressure drug has been recalled because of fears of impurities added by a lab in China. Drug company Sandoz says it has recalled one lot of losartan potassium hydrochlorothiazide tablets. The impurity, known as NDEA, was found in the drug’s key ingredient made by […]

Read More